Major regulatory agencies have issued directives to reduce the risk of side effects associated with NSAIDs while preserving their well-demonstrated analgesic benefits. Specifically, the US Food and Drug Administration and the European Medicines Agency have directed that NSAIDs should be used at the lowest effective dose for shortest duration.

Source: FDA Public Health Advisory 4/7/2005; EMEA Directive 10/18/2006